BPA Call VA25517A0007-36C25518N3035
- This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, including tests for infectious diseases and genetic conditions. The contract, valued at $82,752.48, is a delivery order issued under Cepheid's General Services Administration (GSA) Federal Supply Schedule (FSS) contract for In-Vitro Diagnostics, Reagents, and Test Kits. The contract is for the provision of MRSA, C. diff, and flu test kits to the Department of Veterans Affairs (VA) Veterans...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm-fixed price delivery order contract to Cepheid, a for-profit manufacturer of molecular diagnostics solutions, to provide cost per test services for MRSA nasal, MRSA blood, influenza, C. diff, GC/NG, and other infectious disease tests. The $398,339.20 contract has an August 2019 completion date and was not set aside. Cepheid, a subsidiary of Danaher Corporation, provides reagents, test kits, instruments, and...
- This federal contract award was made by the Department of Veterans Affairs (VA) Veterans Health Administration to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, including tests for infectious diseases. The contract, valued at $679,449.60, is for the delivery of MRSA/C. diff diagnostic products and services, including reagents, test kits, instruments, and testing platforms. The contract was awarded on a firm fixed-price basis under the GSA Scientific Equipment and...
- This federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, is for the delivery of MRSA reagents and GeneXpert test kits. The contract, valued at $319,280.05, was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to support the agency's clinical diagnostic programs. The contract is a Blanket Purchase Agreement (BPA) call under the VA's existing Federal Supply Schedule (FSS) contract for in vitro diagnostics, reagents, and...
- This federal contract award was issued by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 1 to the prime contractor Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The $956,060.20 Firm Fixed Price Delivery Order is for the provision of Cepheid's C-DIFF, MRSA, and H1N1 test kits under the VA's Indefinite Delivery Vehicle for In Vitro Diagnostics, Reagents, and Test products. The contract has no set-aside designation. Cepheid, as the original...
- This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The $104,930.64 contract is for the delivery of MRSA, C-DIFF, and XPRSFLU test kits to support the VA's clinical diagnostic programs. The contract does not have a set-aside designation. Cepheid is the prime contractor and sole provider for this award. As the original equipment manufacturer of the...
- This federal contract award is for the provision of MRSA test kits to the Department of Veterans Affairs (VA) Veterans Integrated Service Network 16. The one-year delivery order, valued at $113,272.92, was awarded on October 1, 2015 to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is a firm fixed-price delivery order under Cepheid's existing General Services Administration (GSA) schedule contract for in vitro diagnostics, reagents, and tests. This award...
- This federal contract award is for Cepheid, a for-profit manufacturer of molecular diagnostic solutions, to provide Cepheid brand reagents, MRSA test kits, and Infinity bags/boxes to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 6. The $2,042,943.98 Firm Fixed Price contract, awarded on October 1, 2019, has a period of performance through September 30, 2020. The award is associated with the Coronavirus COVID-19 national interest...
- This is a firm fixed-price BPA call contract awarded by the Veterans Integrated Service Network 15 (VISN 15) of the U.S. Department of Veterans Affairs (VA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract, with a ceiling value of $7,559,248.97, is for the procurement of MRSA and C. diff test kits to support clinical testing programs serving veterans. The contract is not set aside and is awarded under the VA's Indefinite Delivery Vehicle (IDV) contract for In...
- This federal contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cepheid, a for-profit manufacturer of molecular diagnostic solutions and testing products. The $198,055.70 firm fixed price contract is for the provision of Cepheid's MSRA (Methicillin-Resistant Staphylococcus Aureus) test kits. The contract has a completion date of September 30, 2020 and was awarded on October 1, 2019 without any set-aside designation. Cepheid, a subsidiary of the...
- Invitro Diagnostics, Reagents, Test (FSS-65-VII)Master GSA Schedule
- V797P5967X-VA25517A0007Blanket Purchase Agreement
- VA25517A0007-36C25518N3035BPA Call
This federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, is for the provision of MRSA and C. diff test kits and reagents. The award, valued at $883,413.29, was made by the Department of Veterans Affairs (VA) Veterans Health Administration under a Blanket Purchase Agreement (BPA) call against a General Services Administration (GSA) Schedule contract for In Vitro Diagnostics, Reagents, and Tests. The contract has a firm-fixed price pricing type and a period of performance through April 30, 2020. As the prime contractor, Cepheid, a subsidiary of the Danaher Corporation, supplies diagnostic testing products and services to support the clinical programs of various federal agencies, including the VA, the Defense Logistics Agency, and the Indian Health Service. Cepheid also holds separate contracts and subcontracts related to infectious disease research and COVID-19 testing.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | ($23k) | 9/10/20 | |
| Not listed | Not listed | $906.6k | 6/28/18 |